QP 01 - GU 3: Quick Pitch: Reducing Toxicities of Prostate Radiation

Presentations

• 08:00am - 09:00am PT

  GU 3: Quick Pitch: Reducing Toxicities of Prostate Radiation

  Speaker: Tyler Robin, MD, PhD - University of Colorado School of Medicine, Deptartment of Radiation Oncology, Aurora
• 08:00am - 09:00am PT

  GU 3: Quick Pitch: Reducing Toxicities of Prostate Radiation

  Speaker: Ting Martin Ma, MD, PhD - University of Washington, Seattle
• 08:05am - 08:10am PT

  Second pelvic malignancies in localised prostate cancer treated with radiotherapy: Long-term data from two Phase III Trials

  Speaker: Abdenour Nabid, MD - CHUS, Sherbrooke
• 08:10am - 08:15am PT

  Optimizing Radiation Therapy for Prostate Cancer: Can Dose Reduction to the Pudendal Arteries Preserve Sexual Health?

  Speaker: Sophia Kim-Wang, MD, PhD - University of Chicago, Chicago
• 08:15am - 08:20am PT

  EPIC-26 Longitudinal Analyses of Prostatic Urethral Lift Implant with Stereotactic Ablative Body Radiotherapy for Men with Prostate Cancer and Benign Prostatic Hyperplasia

  Speaker: Young Suk Kwon, MD - University of Texas Southwestern Medical Center at Dallas, Dallas
• 08:20am - 08:25am PT

  Dosimetric Analysis of Post-Radiotherapy Sexual Dysfunction in Patients Receiving Definitive Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer: A Secondary Analysis of MIRAGE

  Speaker: Jonathan Massachi, MD, MS - University of California, Los Angeles, San Francisco
• 08:25am - 08:30am PT

  Driving Improvement in Prostate Cancer Radiotherapy Outcomes through a National Quality Assurance Program: Results from a Large UK Academic Center

  Speaker: Vishal Manik, - Madras Medical College, Chennai
• 08:30am - 08:35am PT

  Acute Toxicity Following Dose-Escalated MRI-Guided SBRT vs. Adapted Dose-Painted MRI-Guided SBRT: A Pooled Comparison of Prospective Trials

  Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles